3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Prostate Cancer Metastatic
1
Colorectal and Ovarian Cancer Patients With Liver Metastases
1
Colorectal Neoplasms
1
Interventions
Prednisone
5
enzalutamide
4
cabazitaxel
4
Docetaxel
3
XRP6258
2
Abiraterone Acetate
2
sipuleucel-T
1
rucaparib
1
olaparib
1
apalutamide
1
Zuclomiphene
1
Standard of Care
1
Prednisolone
1
Lenograstim
1
LY3023414
1
Injections
1
Hematologic Tests
1
Granulocyte Colony-Stimulating Factor
1
Abituzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostate Cancer Metastatic
×
Abituzumab
×
Clear all
NCT01360840
2015-12-14
PERSEUS
EMD Serono
Phase 2
Completed
180 enrolled
23 charts